Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate.

AUTOR(ES)

Bird, A C

RESUMO

Eighteen patients, moderately to heavily infected with onchocerciasis, were treated with a standard course of diethylcarbamazine citrate (DEC-C). In addition to the well recognised systemic reactions to treatment, the following ocular changes occurred during therapy: (1) Transient pigment epithelial lesions were detected in 7 patients by fluorescein angiography. (2) Optic disc leakage, as shown by fluorescein angiography, developed in 9 patients, and increase of pre-existing leakage was demonstrated in 3 further patients. (3) Visual field loss was documented in 5 patients. These observations have grave implications for DEC-C therapy in onchocerciasis. They emphasise the need for great caution in its use in the treatment of onchocerciasis in heavily infected patients and for close supervision of ocular function during therapy.

Documentos Relacionados

• Morphology of posterior segment lesions of the eye in patients with onchocerciasis.
• Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.
• Further studies on the treatment of ocular onchocerciasis with diethylcarbamazine and suramin.
• Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.
• Pulmonary function in tropical eosinophilia before and after treatment with diethylcarbamazine.